PFE, DIS, TSLA, BABA and more

Check out the companies making headlines in premarket trading. Pfizer -- Shares dropped 4.2% after the drugmaker said it would halt development of its twice-daily experimental weight-loss pill. Pfizer said patients in a mid-stage clinical study reported high rates of adverse side effects. It still plans to release trial...